# A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

> **NCT01607762** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Quetiapine
- **DRUG:** Olanzapine
- **DRUG:** Risperidone
- **DRUG:** Paliperidone

## Key facts

- **NCT ID:** NCT01607762
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607762, "A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01607762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*